Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D).

NCT06153420 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

421

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to lack of efficacy compared to placebo.

Conditions

Irritable Bowel Syndrome With Diarrhea

Interventions

DRUG: CIN-103
DRUG: Placebo

Sponsor

CinPhloro Pharma, LLC